Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor
Matthew J. Bellizzi, Shao-Ming Lu, Eliezer Masliah, Harris A. Gelbard
Matthew J. Bellizzi, Shao-Ming Lu, Eliezer Masliah, Harris A. Gelbard
View: Text | PDF
Research Article Neuroscience

Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor

  • Text
  • PDF
Abstract

Neurologic impairment in HIV-1–associated dementia (HAD) and other neuroinflammatory diseases correlates with injury to dendrites and synapses, but how such injury occurs is not known. We hypothesized that neuroinflammation makes dendrites susceptible to excitotoxic injury following synaptic activity. We report that platelet-activating factor, an inflammatory phospholipid that mediates synaptic plasticity and neurotoxicity and is dramatically elevated in the brain during HAD, promotes dendrite injury following elevated synaptic activity and can replicate HIV-1–associated dendritic pathology. In hippocampal slices exposed to a stable platelet-activating factor analogue, tetanic stimulation that normally induces long-term synaptic potentiation instead promoted development of calcium- and caspase-dependent dendritic beading. Chemical preconditioning with diazoxide, a mitochondrial ATP-sensitive potassium channel agonist, prevented dendritic beading and restored long-term potentiation. In contrast to models invoking excessive glutamate release, these results suggest that physiologic synaptic activity may trigger excitotoxic dendritic injury during chronic neuroinflammation. Furthermore, preconditioning may represent a novel therapeutic strategy for preventing excitotoxic injury while preserving physiologic plasticity.

Authors

Matthew J. Bellizzi, Shao-Ming Lu, Eliezer Masliah, Harris A. Gelbard

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
cPAF replaces LTP with dendritic beading in hippocampal slices. (A) Dend...
cPAF replaces LTP with dendritic beading in hippocampal slices. (A) Dendritic beading (arrows) in a cPAF-exposed CA1 pyramidal neuron 45 minutes after high-frequency Schaffer collateral stimulation (HFS) with no disruption of dendrite or spine morphology in following HFS in vehicle-treated cells. (B) HFS elicited dendritic beading in 11 of 19 cells from cPAF-treated slices and in 0 of 13 cells from vehicle-treated slices. *P < 0.001. PAF-R antagonists BN52021 and CV-3988 reduced dendritic beading to 1 of 10 and 1 of 7 cells, respectively. **P < 0.05 vs. cPAF. (C) The amplitude and duration of postsynaptic depolarization during HFS is unaffected by cPAF exposure. (D) Excitatory synaptic transmission is strongly potentiated following HFS in vehicle-treated slices (2.66 ± 0.44–fold relative to baseline at 40 to 50 minutes, n = 13, P < 0.001). In cPAF-treated slices, cells that did not develop dendritic beading underwent a smaller but significant potentiation (1.60 ± 0.26 relative to baseline, n = 8, P < 0.05) while EPSPs in cells whose dendrites did bead were not potentiated at all (0.84 ± 0.12 relative to baseline, n = 11, P < 0.01 vs. vehicle and P < 0.05 vs. cPAF-treated cells without dendritic beading). Representative EPSPs from vehicle-treated (upper right) and beaded cPAF-treated cells (lower right) are averages of 10 consecutive traces recorded at baseline and 50 minutes after HFS. Scale bars: 20 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts